CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds will present recent updates and meet one-on-one with investors during the Lazard Capital Markets 8th Annual Healthcare Conference November 15-16 at The Pierre Hotel in New York City.
